Molecular Data Inc. (MKDTY) operates as a technology-driven platform providing one-stop services for the chemical and pharmaceutical industries, including online sales of over 10 million chemical compounds, big data analytics on molecular structures and properties, supply chain management solutions, and research and development support tools. The company offers core products and services such as the Molbase.cn B2B marketplace for bulk chemical procurement; AI-powered molecular search and prediction databases covering synthesis routes, patents, and supplier matching; laboratory services encompassing custom synthesis, compound screening, and CRO (contract research organization) capabilities; and digital platforms like ChemNow for real-time pricing and inventory data across thousands of suppliers. Headquartered in Shanghai, China, and founded in 2013, Molecular Data primarily serves pharmaceutical companies, biotech firms, research institutions, and chemical manufacturers in China and internationally, with expanding operations in Asia-Pacific regions. In recent developments within the last two years, the company has pursued strategic expansions in AI-driven drug discovery tools and formed alliances with leading Chinese chemical producers to enhance its supply chain ecosystem; it also launched enhanced blockchain-based traceability services for chemical sourcing amid growing regulatory demands in 2024.